For developing a bioartificial liver (BAL) device, an attractive alternative to the primary human hepatocytes would be the use of highly differentiated immortalized human hepatocytes with a safeguard. To test the feasibility, the primary human hepatocytes were immortalized by a plasmid SV3neo encoding simian virus 40 large T antigen (SV40Tag) gene. A highly differentiated hepatocyte line OUMS-29 was established. A suicide gene of herpes simplex virus-thymidine kinase (HSV-TK) was retrovirally introduced into OUMS-29 cells as a safeguard for clinical application. One of the resulting HSV-TK-positive cell lines, OUMS-29/ tk, grew in chemically defined serum-free medium with the gene expression of differentiated liver functions. OUMS-29/tk cells were 100 times more sensitive to ganciclovir compared with unmodified OUMS-29 cells in in vitro experiments. We have established a tightly regulated immortalized human hepatocyte cell line. Essentially unlimited availability of OUMS-29/tk cells may be clinically useful for BAL therapy.
INTRODUCTION
gene was retrovirally introduced into OUMS-29 cells as a safeguard for a clinical application. This work repre-Considering the regenerating potential of patients sents a potential novel strategy for resolving the organ with acute liver failure (ALF), a temporary metabolic shortage that currently limits the use of human primary support for devastated hepatic functions could rescue the hepatocytes for BAL treatment. patients without requiring liver transplantation. Bioartificial liver (BAL) is a one of the promising treatments for ALF (9). This form of therapy requires a number of MATERIALS AND METHODS actively functional cells. A worldwide shortage of hu-Cell Immortalization and Culture man livers for hepatocyte isolation is one of the major Briefly, intact human hepatocytes were isolated from hurdles of BAL therapy. To overcome this issue, we prethe liver of a legally aborted 21-week-old male fetus by viously established a highly differentiated immortalized the standard two-step collagenase perfusion technique, human hepatocyte cell line OUMS-29 using simian virus as previously described (3). Hepatocytes were transfec-40 large T antigen (SV40Tag) (3). However, the potented with a plasmid pSV3neo containing the genes of SVtial risk of using the immortal cells for humans cannot 40Tag and bacterial neomycin phosphotransferase. One be precluded, even though they are not tumorigenic. Usof the immortalized clones, OUMS-29, showed highly ing currently available technology, several safeguards differentiated liver functions and grew steadily in chemishould be considered to make OUMS-29 cells more cally defined serum-free medium ASF104 (Ajinomoto clinically useful.
Co., Tokyo, Japan) (3). The herpes simplex virus-thymidine kinase (HSV-TK) gene has been shown to facilitate selective cell kill-Introduction of the HSV-TK Gene Into OUMS-29 Cells ing by metabolizing nucleoside analogs such as GCV into "suicide nucleotides" that kill cells by inhibiting de-OUMS-29 cells were transduced with the supernatant of Ÿ Crip cells, which produce a recombinant retrovirus oxyribonucleic acid synthesis (5). HSV-TK gene has been successfully used to eliminate tumor cells in a vari-that encodes a fusion gene combining hygromycin resistance (HygroR) with HSV-TK. Two days after the final ety of animal models. In the present study, HSV-TK 374 KOBAYASHI ET AL. transduction, the cells were maintained with 320 µg/ml RESULTS hygromycin-containing ASF104 medium. The trans-Transduction of OUMS-29 Cells With a Retrovirus duced colonies emerged within 14 days. Then individual Vector Encoding the HSV-TK Gene colonies were isolated using a cloning ring and ex-OUMS-29 cells were transduced with a retrovirus panded in tissue culture. One of the cloned hepatocytes, vector expressing a fused gene of HygroR and HSV-TK. OUMS-29/tk, was used in the present studies based on After selection with 320 µg/ml hygromycin, one of the growth characteristics and morphology.
surviving cells, OUMS-29/tk, grew in ASF104 medium and doubled in number in approximately 48 h. OUMS-In Vitro Sensitivity of OUMS-29/tk Cells to Ganciclovir 29/tk cells showed morphological characteristics of liver To examine the in vitro sensitivity of OUMS-29/tk parenchymal cells such as large round nucleus with cells to ganciclovir (GCV, kindly given by Tanabe Phara few nucleoli and many granules in the cytoplasm maceutical Inc., Osaka, Japan), the cells were inoculated ( Fig. 1 ). at 3 × 10 3 cells per well on 96-well microplates. OUMS-In Vitro Sensitivity of OUMS-29/tk Cells to 29/tk cells were maintained with 5 µM GCV-containing Ganciclovir (GCV) ASF104 medium to obtain a growth curve. Unmodified OUMS-29 cells were cultured with the medium contain-To examine the GCV killing effect to OUMS-29/tk ing 500 µM GCV. On days 1, 3, 5, and 7, 2 µg of subcells, the cells were cultured with 5 µM GCV-containing strate of 5-diphenyl-2H tetrazolium bromide (MTT) was ASF104 medium. As shown in Figure 2 , OUMS-29/tk added to each well, incubated for 4 h at 37°C, then recells showed sensitivity to 5 µM GCV, whereas unmodiacted with 150 µl isopropanol for 10 min. The relative fied OUMS-29 cells grew normally in ASF104 containpercent viability was determined by the ratio of absorbing 500 µM GCV. OUMS-29/tk cells were >100 times ance of 570 and 630 µm using Bio-Rad EIA reader more sensitive to GCV than unmodified OUMS-29 (Richmond, CA).
cells. Under the administration of 5 µM GCV, OUMS-29/tk cells died over a 2-week period (Fig. 3 ).
Gene Expression of Liver Functions in Gene Expression of Differentiated Liver Functions in OUMS-29/tk Cells OUMS-29/tk Cells Total RNA was isolated from OUMS-29/tk cells us-
The RT-PCR analysis was performed to examine the ing RNAzol (Cinna/BioTecx, Friendswood, TX) in a gene expression of differentiated liver functions in single-step phenol extraction method and used as tem-OUMS-29/tk cells. The cells expressed the genes includplates. Reverse transcription (RT) was performed at ing albumin, ASGPR, GS, GST-π, and HBCF-X, as 22°C for 10 min and then 42°C for 20 min using 1.0 µg shown in Figure 4 . of RNA per reaction. Polymerase chain reaction (PCR) was performed with specific primers in volumes of 50 DISCUSSION µl containing 2.0 µg RT products according to the man-Liver transplantation has been the only therapeutic ufacturer's protocol (PCR kit; Perkin-Elmer/Cetus, Normodality to treat patients with acute liver failure (ALF); walk, CT) as previously described (3). Primers used were as follows: albumin (576 base pair, bp), AAACCT CTTGTGGAAGAGCC (5′ primer) and CAAAGCAG GTCTCCTTATCG (3′ primer); asialoglycoprotein receptor (ASGPR, 495 bp), TAGGAGCCAAGCTGGAG AAA (5′ primer) and ACCTGCAGGCAGAAGTCATC (3′ primer); glutamine synthetase (GS, 535 bp), ATGC TGGAGTCAAGATTGCG (5′ primer) and TCATTGA GAAGACACGTGCG (3′ primer); glutathione-S-transferase π (GST-π, 496 bp), GCCCTACACCGTGGTCT ATT (5′ primer) and GGCTAGGACCTCATGGATCA (3′ primer); human blood coagulation factor X (HBCF-X, 493 bp), GTGCATGGAAGAGACCTGCT (5′ primer) and GAAGTCAAGCAGGTCGAAGG (3′ primer); human β-actin (610 bp), TGACGGGGTCACCCACACT GTGCCCATCTA (5′ primer) and CTAGAAGCATTT GCGGTGGACGATGGAGGG (3′ primer). The human have to be replaced frequently for continuous use. On the other hand, human cell lines derived from in vivo however, less traumatic therapies should be investigated liver tumors can avoid the potential xenogeneic immune because of the considerable risks associated with transresponse. However, a potential risk of the use of these plantation. The ultimate goal of liver support devices transformed cells for BAL therapy would be the transsuch as bioartificial liver (BAL) is to maintain patients mission of tumor cells or tumorigenic products from the with liver insufficiency until their own liver regenerates, BAL device into the patient's circulation (2, 13) . thereby obviating the need for costly liver transplanta-An attractive solution to these issues would be to use tion and long-term immunosuppression. Because it is a tightly regulated human cell line that grows economiconsidered that at least 15% of normal liver mass is recally in culture and exhibits the characteristics of differquired to provide ALF patients with sufficient function, entiated hepatocytes. For the first step toward this goal, the BAL treatment requires a large number of hepatowe immortalized human hepatocytes with a plasmid SVcytes. The primary human hepatocytes are the most suit-3neo containing SV40Tag gene. One of the resulting able source for BAL therapy; however, they have a limclones, OUMS-29, showed highly differentiated liver ited life span and their functional activities decline functions and provided a metabolic support during exrapidly after several days in currently available culture perimental ALF in rats (3). OUMS-29 cells were not conditions. In addition, the availability of human livers tumorigenic when transplanted into the athymic nude for hepatocyte isolation is severely limited.
mice, but the potential risks of using the cells in human For these reasons, isolated pig hepatocytes or a liver could not be completely denied (3). In fact, stable xenocell line C3A, clonally derived from a human hepatoblastoma, have been used as a source of hepatic functions in BAL (7-10). The advantages of using the pig are the ready availability as a source of hepatocytes and the fact that the pig is considered to be physiologically closer to man than other domestic animals. The potential immunologic problems with hepatocytes of different species are unlikely to be a major limitation to shortterm use in patients with ALF, but this will not be the 499; 1980. humans (1, 6) 
